MedPath

Crenobalneotherapy in the Treatment of Chronic Venous Insufficiency

Phase 3
Completed
Conditions
Balneology
Registration Number
NCT01956318
Lead Sponsor
Centre de Recherche Rhumatologique et Thermal
Brief Summary

At 3 months, crenobalneotherapy session is superior to waiting list for patients with chronic venous insufficiency.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
99
Inclusion Criteria
  • patients aged 18 to 80 years with chronic venous insufficiency regardless of etiology stages 3 or 4 according to the CEAP classification (Clinical severity, Etiology or cause, Anatomy, Pathophysiology)
  • Patients available to participate in a 3 weeks session in the spa center and to be followed for 6 months
Exclusion Criteria
  • pregnant women,
  • contra-indication for the spa treatment (chronic infectious diseases, cancer, heart failure, serious liver or kidney disease, open leg ulcer, psychiatric disorders, immune deficiency, phlebitis, erysipelas or history of erysipelas);
  • surgery in the next three months,
  • spa treatment in the previous 6 months,
  • professional involvement with a spa resort

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
number of patient with 20% improvement of CIVIC scale at 3 months3 months

Primary outcome is the number of patient with 20% improvement in quality of life (CIVIC scale) at 3 months

Secondary Outcome Measures
NameTimeMethod
CIVIC1 month

Chronic Venous Insufficiency Questionnaire (CIVIQ 2) 20% improvement. disease-specific QOL score for patients with chronic venous disease. The total score is derived from 20 questions (items) that represent four QOL dimensions (of 3-9 items each): bodily pain, physical, social and psychological functioning. The possible scores for each item are as follows: 1, negative; 2, weak; 3, moderate; 4, strong; 5, severe. The total scores can therefore vary from 20 (no symptoms) to 100 (worse possible condition).

civic1 & 3 months

evolution of civic scale

Rutherford severity score1 & 3 months

clinical evaluation of severity taking into account 10 attributes: pain, varicose veins, venous edema, skin pigmentation, and adherence to compressive therapy, inflammation, induration, number, size and duration of active ulcer. Each attribute is scored 0 (minimum) to 2 (maximum).

PASS1 & 3 months

PASS is measured by asking the patient if he/she feels he/she is in an acceptable clinical condition in terms of its venous insufficiency. We measure the number of patients with PASS

opinion of patient and practitionner1 & 3 months

Opinion of patient and practitioner is determined on a 5 point Lickert scale (very aggravated, aggravated, unchanged, improved and very improved)

associated treatment1 & 3 months

Drug consumption is estimated on the last 3 days prior to the evaluation. Surgery, hospitalization for venous insufficiency and adherence to compression therapy

side effectsweek 1 & 3. 1 & 3 months

side effects are collected by therapists and assessor. we collected the number of patients with side effects and the type of side effect

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.